German Roberto Perez

Dr. German Roberto Perez

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Journal of General Virology
Verified
Journal Article
Open access
DCDiego Chouhy
Diego Chouhy
EBElisa M. Bolatti
Elisa M. Bolatti
GPGerman Roberto Perez
German Roberto Perez
AGAdriana A. Giri
Adriana A. Giri
More than 170 human papillomavirus (HPV) types have been completely sequenced, curated and divided into five genera: Alphapapillomavirus, Betapapillomavirus, Gammapapillomavirus, Mupapillomavirus and Nupapillomavirus. With the application of PCR methods, hundreds of putative novel HPV types have been identified as PCR amplicons in mucosa and skin. However, at present there are no studies reporting a systematic search of the currently known L1 amplicons and their phylogenetic relationships. This survey revealed the existence of at least 202 different putative HPV types that are pending for full-genome characterization: five alphapapillomaviruses, 37 betapapillomaviruses, 159 gammapapillomaviruses and one mupapillomavirus. All potential viruses of the genera Alphapapillomavirus and Betapapillomavirus were grouped in the defined species, while 59 putative gammapapillomaviruses types were segregated in 21 unidentified putative species. These data highlight the need for progress in the identification of additional taxa of the family Papillomaviridae in order to elucidate the diversity, evolution and medical implications of these viruses.

1 April 2015 in Molecular Phylogenetics and Evolution
Verified
Journal Article
Closed access
PCPablo E. Casal
Pablo E. Casal
DCDiego Chouhy
Diego Chouhy
EBElisa M. Bolatti
Elisa M. Bolatti
GPGerman Roberto Perez
German Roberto Perez
ESEmma J. Stella
Emma J. Stella
AGAdriana A. Giri
Adriana A. Giri

1 August 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
Elisa BolattiElisa Bolatti
Elisa Bolatti
DCDiego Chouhy
Diego Chouhy
PCPablo E. Casal
Pablo E. Casal
GPGerman Roberto Perez
German Roberto Perez
ESEmma J. Stella
Emma J. Stella
AGAdriana A. Giri
Adriana A. Giri

28 November 2007 in Transplantation Reviews
Verified
Journal Article
Closed access
DHDomingo Hernandez
Domingo Hernandez
MRMargarita Rufino
Margarita Rufino
JGJosé Manuel González-Posada
José Manuel González-Posada
SESara Estupiñán
Sara Estupiñán
GPGerman Roberto Perez
German Roberto Perez
JPJulio Pascual
Julio Pascual

31 May 2021 in Molecular and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
MRMaría Fernanda Ruiz
María Fernanda Ruiz
MGMaría Verónica Gennaro
María Verónica Gennaro
LBLaura C. Bastone
Laura C. Bastone
AGAlicia R. Godoy
Alicia R. Godoy
MTMónica Torruella
Mónica Torruella
GPGerman Roberto Perez
German Roberto Perez
The present study aimed to evaluate the impact caused by the 2016 World Health Organization (WHO) diagnostic classification of gliomas in 139 patients studied in Argentina. Formalin‑fixed paraffin‑embedded tissues were used for histological and immunohistochemical analysis [glial fibrillary acidic protein, KI67, synaptophysin and isocitrate dehydrogenase (IDH)1‑R132H]. DNA from formalin‑fixed paraffin‑embedded tissues was used for molecular analysis: 1p/19q co‑deletion and mutation status of the IDH gene. These experiments were performed by direct Sanger sequencing and multiplex ligation‑dependent probe amplification. According to the new classification, diagnoses included oligodendroglioma IDH‑mutant and 1p/19q co‑deletion (4.20%), anaplastic oligodendroglioma IDH‑mutant and 1p/19q co‑deletion (2.52%), diffuse astrocytoma IDH‑mutant (6.72%), diffuse astrocytoma IDH‑wild type (1.68%), anaplastic astrocytoma IDH‑mutant (5.04%), anaplastic astrocytoma IDH‑wild type (8.40%), glioblastoma IDH‑mutant (5.88%) and glioblastoma IDH‑wild type (65.56%). Regarding tumor histology, 60% of oligodendrogliomas, 35% of astrocytoma and 100% of unclassified gliomas were re‑classified, while glioblastomas maintained their initial classification. Additionally, the present study evaluated the prognostic value of the histological grade for the 2007 and 2016 WHO classifications of gliomas. The histological subgroup associated with longer overall survival (OS) was grade II glioma (OS‑2007WHO, 35.6 months; and OS‑2016WHO, 47.7 months). Glioblastoma was the subgroup associated with a poor outcome (OS‑2007WHO, 10.4 months; and OS‑2016WHO, 11.1 months). The present study evaluated the OS of tumor grade subgroups with respect to their IDH status. For all subgroups, IDH‑mutant tumors were associated with an improved prognosis compared with IDH‑wild type tumors. The results suggested that the incorporation of molecular biomarkers in the new WHO classification improves tumor characterization and prognostic value of the subgroups.

1 November 2007 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
GVGabriela Vanina Villanova
Gabriela Vanina Villanova
DGDaniela Gardiol
Daniela Gardiol
MTMiguel A. Taborda
Miguel A. Taborda
VRVirginia Reggiardo
Virginia Reggiardo
HTHugo Tanno
Hugo Tanno
AGAdriana A. Giri
Adriana A. Giri
Molecular diagnostics based on reverse transcription (RT)-PCR are routinely complicated by the lack of stable internal controls, leading to falsely negative results. We describe a strategy to produce a stable competitive internal control (CIC) based on a Qβ phage derivative (recombinant Qβ [rQβ]) bearing primers KY78 and KY80, which are widely used in the detection of hepatitis C virus (HCV). rQβ was RNase resistant and stable at 4°C for 452 days in SM medium (0.1 M NaCl, 8 mM MgSO 4 ·7H 2 O, 50 mM Tris HCl [pH 7.5], 2% gelatin) and for 125 days after lyophilization and reconstitution. rQβ performance as a CIC was evaluated. rQβ was added to HCV-positive samples, followed by RNA extraction and a CIC-HCV RT-PCR assay. This method combines RT-PCR, liquid hybridization with nonradioactive probes, and enzyme immunoanalysis. No influence of the CIC on qualitative HCV detection was observed independently of viral load, and results had high concordance with those of commercial kits. In conclusion, we describe a versatile, low-cost alternative strategy to armored RNA technology that can be adapted for detection or real-time applications of any RNA target. Moreover, the CIC reported here is an essential reagent for HCV screening in blood banks in resource-limited settings.